New York, NY, United States of America

Andrzej Zatorski

This inventor holds 1 USPTO granted patent. Top assignee: Sloan-Kettering Institute for Cancer Research. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrzej Zatorski. Retrieved from https://idiyas.com/inventor/andrzej-zatorski

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Andrzej Zatorski

Introduction

Andrzej Zatorski is a notable inventor based in New York, NY. He has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds that can aid in treating specific disorders.

Latest Patents

Zatorski holds a patent for a C-nucleoside isostere of nicotinamide adenine dinucleotide and its analogs. This invention provides a compound with a complex structure, where each component can vary, allowing for a range of potential applications. The patent also includes a pharmaceutical composition that comprises these compounds and methods for treating mammals with inosine monophosphate dehydrogenase associated disorders.

Career Highlights

Zatorski is affiliated with the Sloan-Kettering Institute for Cancer Research, where he continues to work on innovative solutions in cancer treatment. His research focuses on the development of new therapeutic compounds that can improve patient outcomes.

Collaborations

He has collaborated with notable colleagues such as Krysztof W. Pankiewicz and Kyoichi A. Watanabe, contributing to a rich environment of innovation and discovery.

Conclusion

Andrzej Zatorski's work exemplifies the impact of innovative research in the pharmaceutical field. His contributions continue to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…